{
  "ticker": "LLY",
  "target_date": "2024-12-27",
  "actual_date": "2024-12-27",
  "collected_at": "2025-12-08T11:12:18.899770",
  "price": {
    "open": 784.15,
    "high": 787.43,
    "low": 773.45,
    "close": 777.3717041015625,
    "volume": 2096500,
    "change_1d_pct": -1.38,
    "change_7d_pct": 0.58,
    "change_30d_pct": -3.37
  },
  "technicals": {
    "rsi_14": 33.82,
    "sma_20": 788.03,
    "sma_50": 804.69,
    "macd": -6.058,
    "macd_signal": -7.987,
    "macd_histogram": 1.929,
    "bb_upper": 827.51,
    "bb_lower": 748.56,
    "price_vs_sma20_pct": -1.35,
    "price_vs_sma50_pct": -3.4,
    "volume_ratio": 0.64
  },
  "fundamentals": {
    "market_cap": 890450477056,
    "pe_ratio": 48.66732,
    "forward_pe": 43.83495,
    "price_to_book": 37.398342,
    "price_to_sales": 14.985754,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.67,
    "pct_from_52w_low": 59.24
  },
  "macro": {
    "spy": {
      "price": 589.84,
      "change_1d_pct": -1.05,
      "change_7d_pct": 1.83
    },
    "vix": {
      "level": 15.95,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.62
    },
    "dollar_index": {
      "level": 108.0
    },
    "gold": {
      "price": 2617.2
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Tesla's Musk Uses Weight-Loss Drugs as Eli Lilly and Novo Nordisk Dominate the Market",
      "source": "Yahoo",
      "datetime": 1735325284,
      "summary": "Musk revealed using Novo Nordisk's Ozempic and Eli Lilly's Mounjaro, highlighting their popularity for weight management.",
      "url": "https://finnhub.io/api/news?id=b217155a465da8ef3498efdea19b2f509a2b7c99c666047829f1eee7fd866a5a"
    },
    {
      "headline": "The Dogs of the Dow Could Soon Have Their Day",
      "source": "MarketWatch",
      "datetime": 1735321740,
      "summary": "The Dogs of the Dow Could Soon Have Their Day",
      "url": "https://finnhub.io/api/news?id=213346eb138c66b7a9cac29de6d8c659e4d8b55ee2ba5e5f51dad4513697600f"
    },
    {
      "headline": "Duvakitug And Teva's Growth: A Game Changer In Pharma",
      "source": "SeekingAlpha",
      "datetime": 1735312889,
      "summary": "Teva Pharmaceutical Industries continues to impress investors with strong sales growth and promising development. Click here to find out why TEVA is a Buy.",
      "url": "https://finnhub.io/api/news?id=f932524cce0ab7e6732fb2bdfb867eccfcc2050d50d49631a3b1c7b1033d3814"
    },
    {
      "headline": "3 Healthcare Stocks to Buy for a 2025 Rebound",
      "source": "Yahoo",
      "datetime": 1735282800,
      "summary": "Healthcare stocks have gotten crushed in 2024, and next year doesn\u2019t look much better.  Recent developments, including a bipartisan bill calling for insurers to separate from their pharmacy benefit management units, or PBMs, has caused pain, but the sector has been unloved for most of the last 11 mo",
      "url": "https://finnhub.io/api/news?id=3708c7a3927019e64f3137eb67d5009f9f5bed7f8b42aece67fae6163ec3675f"
    },
    {
      "headline": "Healthcare: Why the sector underperformed in 2024",
      "source": "Yahoo",
      "datetime": 1735228380,
      "summary": "The healthcare sector (XLV) faced significant challenges in the markets throughout 2024, becoming the worst-performing S&P 500 (^GSPC) sector of the year. Yahoo Finance Senior Health Reporter Anjalee Khemlani analyzes the key market themes that influenced the sector this year and examines investor s",
      "url": "https://finnhub.io/api/news?id=c3da17b70c9a620e3f7353d5ef8a3740e69c98057f073b548babe5271da4bc9f"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470584.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000291/xslF345X05/wk-form4_1734470584.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470498.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000289/xslF345X05/wk-form4_1734470498.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470366.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000287/xslF345X05/wk-form4_1734470366.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470270.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000285/xslF345X05/wk-form4_1734470270.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470180.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000283/xslF345X05/wk-form4_1734470180.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}